Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Vadai E

Collect these papers and discover other ones on Labmeeting. Learn more.

A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice.

+ cite this

+ View Abstract

Merbl Y, Itzchak R, Vider-Shalit T, Louzoun Y, Quintana FJ, Vadai E, Eisenbach L, and Cohen IR

PLoS ONE 4(6):e6053, 2009 - Who cited this? | PubMed ID: 19557135 | Fulltext

Exuberated numbers of tumor-specific T cells result in tumor escape.

+ cite this

+ View Abstract

Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, and Eisenbach L

Cancer research 68(9):3450, 2008 May 1 - Who cited this? | PubMed ID: 18451173 | Fulltext

'1-8 interferon inducible gene family': putative colon carcinoma-associated antigens.

+ cite this

+ View Abstract

Tirosh B, Daniel-Carmi V, Carmon L, Paz A, Lugassy G, Vadai E, Machlenkin A, Bar-Haim E, Do MS, Ahn IS, Fridkin M, Tzehoval E, and Eisenbach L

British journal of cancer 97(12):1655, 2007 Dec 17 - Who cited this? | PubMed ID: 18071348 | Fulltext

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

+ cite this

+ View Abstract

Machlenkin A, Azriel-Rosenfeld R, Volovitz I, Vadai E, Lev A, Paz A, Goldberger O, Reiter Y, Tzehoval E, Benhar I, and Eisenbach L

Cancer immunology, immunotherapy : CII 56(2):217, 2007 Feb - Who cited this? | PubMed ID: 16738849 | Fulltext

O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.

+ cite this

+ View Abstract

Stepensky D, Tzehoval E, Vadai E, and Eisenbach L

Clinical and experimental immunology 143(1):139, 2006 Jan - Who cited this? | PubMed ID: 16367945 | Fulltext

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy.

+ cite this

+ View Abstract

Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier F, Tzehoval E, and Eisenbach L

Cancer research 65(14):6435, 2005 Jul 15 - Who cited this? | PubMed ID: 16024648 | Fulltext

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

+ cite this

+ View Abstract

Machlenkin A, Goldberger O, Tirosh B, Paz A, Volovitz I, Bar-Haim E, Lee SH, Vadai E, Tzehoval E, and Eisenbach L

Clinical cancer research : an official journal of the American Association for Cancer Research 11(13):4955, 2005 Jul 1 - Who cited this? | PubMed ID: 16000595 | Fulltext

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides.

+ cite this

+ View Abstract

Bar-Haim E, Paz A, Machlenkin A, Hazzan D, Tirosh B, Carmon L, Brenner B, Vadai E, Mor O, Stein A, Lemonnier FA, Tzehoval E, and Eisenbach L

British journal of cancer 91(2):398, 2004 Jul 19 - Who cited this? | PubMed ID: 15213716 | Fulltext

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

+ cite this

+ View Abstract

Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, and Eisenbach L

Cancer gene therapy 11(3):237, 2004 Mar - Who cited this? | PubMed ID: 14739939 | Fulltext

Expression of FasL by tumor cells does not abrogate anti-tumor CTL function.

+ cite this

+ View Abstract

Lee SH, Bar-Haim E, Goldberger O, Reich-Zeliger S, Vadai E, Tzehoval E, and Eisenbach L

Immunology letters 91(2-3):119, 2004 Feb 15 - Who cited this? | PubMed ID: 15019279 | Fulltext

Cu/Zn superoxide dismutase plays a role in angiogenesis.

+ cite this

+ View Abstract

Marikovsky M, Nevo N, Vadai E, and Harris-Cerruti C

International journal of cancer. Journal international du cancer 97(1):34-41, 2002 Jan 1 - Who cited this? | PubMed ID: 11774241 | Fulltext

Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing.

+ cite this

+ View Abstract

Tirosh B, Fridkin M, Tzehoval E, Vadai E, Lemonnier FA, and Eisenbach L

Journal of immunotherapy (Hagerstown, Md. : 1997) 23(6):622 - Who cited this? | PubMed ID: 11186150 | Fulltext

Anti-tumor vaccination in heterozygous congenic F1 mice: presentation of tumor-associated antigen by the two parental class I alleles.

+ cite this

+ View Abstract

Carmon L, Tzehoval E, Tirosh B, el-Shami KM, Bar-Haim E, Vadai E, Feldman M, and Eisenbach L

Journal of immunotherapy (Hagerstown, Md. : 1997) 23(3):344 - Who cited this? | PubMed ID: 10838663 | Fulltext

Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide.

+ cite this

+ View Abstract

el-Shami KM, Tirosh B, Popovic D, Carmon L, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

International journal of cancer. Journal international du cancer 85(2):236, 2000 Jan 15 - Who cited this? | PubMed ID: 10629083 | Fulltext

Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines.

+ cite this

+ View Abstract

el-Shami KM, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 19(12):1391, 1999 Dec - Who cited this? | PubMed ID: 10638708 | Fulltext

Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination.

+ cite this

+ View Abstract

Tirosh B, El-Shami K, Vaisman N, Carmon L, Bar-Haim E, Vadai E, Feldman M, Fridkin M, and Eisenbach L

Immunology letters 70(1):21, 1999 Oct 1 - Who cited this? | PubMed ID: 10541048 | Fulltext

MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope.

+ cite this

+ View Abstract

El-Shami K, Tirosh B, Bar-Haim E, Carmon L, Vadai E, Fridkin M, Feldman M, and Eisenbach L

European journal of immunology 29(10):3295, 1999 Oct - Who cited this? | PubMed ID: 10540341 | Fulltext

Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.

+ cite this

+ View Abstract

Popovic D, el-Shami KM, Vadai E, Feldman M, Tzehoval E, and Eisenbach L

Clinical & experimental metastasis 16(7):623, 1998 Oct - Who cited this? | PubMed ID: 9932609 | Fulltext

Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas.

+ cite this

+ View Abstract

Mandelboim O, Bar-Haim E, Vadai E, Fridkin M, and Eisenbach L

Journal of immunology (Baltimore, Md. : 1950) 159(12):6030, 1997 Dec 15 - Who cited this? | PubMed ID: 9550401 | Fulltext

DAP kinase links the control of apoptosis to metastasis.

+ cite this

+ View Abstract

Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, and Kimchi A

Nature 390(6656):180, 1997 Nov 13 - Who cited this? | PubMed ID: 9367156 | Fulltext

Modification of PDGFalpha receptor expression or function alters the metastatic phenotype of 3LL cells.

+ cite this

+ View Abstract

Fitzer-Attas CJ, Do MS, Feigelson S, Vadai E, Feldman M, and Eisenbach L

Oncogene 15(13):1545, 1997 Sep 25 - Who cited this? | PubMed ID: 9380406 | Fulltext

Tuftsin-THF-gamma 2 chimeric peptides: potential novel immunomodulators.

+ cite this

+ View Abstract

Granoth R, Vadai E, Burstein Y, Fridkin M, and Tzehoval E

Immunopharmacology 37(1):43-52, 1997 Aug - Who cited this? | PubMed ID: 9285243 | Fulltext

Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.

+ cite this

+ View Abstract

Mandelboim O, Vadai E, Feldman M, and Eisenbach L

Gene therapy 2(10):757-65, 1995 Dec - Who cited this? | PubMed ID: 8750016 | Fulltext

Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.

+ cite this

+ View Abstract

Porgador A, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

Cancer research 55(21):4941-9, 1995 Nov 1 - Who cited this? | PubMed ID: 7585534 | Fulltext

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides.

+ cite this

+ View Abstract

Mandelboim O, Vadai E, Fridkin M, Katz-Hillel A, Feldman M, Berke G, and Eisenbach L

Nature medicine 1(11):1179-83, 1995 Nov - Who cited this? | PubMed ID: 7584991 | Fulltext

Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV).

+ cite this

+ View Abstract

Plaksin D, Porgador A, Vadai E, Feldman M, Schirrmacher V, and Eisenbach L

International journal of cancer. Journal international du cancer 59(6):796-801, 1994 Dec 15 - Who cited this? | PubMed ID: 7989121 | Fulltext

Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.

+ cite this

+ View Abstract

Porgador A, Tzehoval E, Vadai E, Feldman M, and Eisenbach L

Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 14(3):191-201, 1993 Oct - Who cited this? | PubMed ID: 7905286 | Fulltext

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.

+ cite this

+ View Abstract

Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, and Eisenbach L

Cancer research 52(13):3679-86, 1992 Jul 1 - Who cited this? | PubMed ID: 1617640 | Fulltext

Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor.

+ cite this

+ View Abstract

Porgador A, Brenner B, Vadai E, Feldman M, and Eisenbach L

International journal of cancer. Supplement = Journal international du cancer. Supplement 6:54-60, 1991 - Who cited this? | PubMed ID: 1906054 | Fulltext

Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.

+ cite this

+ View Abstract

Gelber C, Plaksin D, Vadai E, Feldman M, and Eisenbach L

Cancer research 49(9):2366-73, 1989 May 1 - Who cited this? | PubMed ID: 2784997 | Fulltext

Search Google Scholar for Vadai E

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!